SEC Form 4 · accession 0000899243-18-025705
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Susan Sender
Officer — See Remarks
Period of report
Sep 27, 2018
Accepted (ET)
Oct 1, 2018 · 9:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 27, 2018 | F | 819 | $122.22 | D | 14,207 | D | |
| Common Stock | Sep 27, 2018 | F | 819 | $122.22 | D | 13,388 | D | |
| Common Stock | Sep 27, 2018 | F | 819 | $122.22 | D | 12,569 | D | |
| Common StockF1 | holding | — | — | — | 63 | I | Through 401(k) Plan |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The information in this report is based on a plan statement dated as of June 30, 2018.
Remarks
Chief Clinical Officer